These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6345004)

  • 21. Studies of the T-lymphocytes resident in the spleens of thymectomized, irradiated, bone marrow-reconstituted (TXB) mice.
    Gillette RW
    Cell Immunol; 1976 Dec; 27(2):200-13. PubMed ID: 12871
    [No Abstract]   [Full Text] [Related]  

  • 22. Inbred mouse strain resistance to Mycobacterium lepraemurium follows the Ity/Lsh pattern.
    Brown IN; Glynn AA; Plant J
    Immunology; 1982 Sep; 47(1):149-56. PubMed ID: 6749659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival of Mycobacterium lepraemurium in C57BL mice after acquired protective immunity.
    Løvik M; Closs O
    Clin Exp Immunol; 1984 Jul; 57(1):115-22. PubMed ID: 6378458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T-cell responsiveness in Mycobacterium lepraemurium infections in a "resistant" (CBA) and a "susceptible" (BALB/c) mouse strain.
    Brett SJ
    Cell Immunol; 1984 Nov; 89(1):132-43. PubMed ID: 6386189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resistance to subcutaneous infection with Mycobacterium lepraemurium is controlled by more than one gene.
    Curtis J; Turk JL
    Infect Immun; 1984 Mar; 43(3):925-30. PubMed ID: 6365787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of the major histocompatibility complex in resistance and granuloma formation in response to Mycobacterium lepraemurium infection.
    Adu HO; Curtis J; Turk JL
    Infect Immun; 1983 May; 40(2):720-5. PubMed ID: 6220974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant interleukin-2 limits the replication of Mycobacterium lepraemurium and Mycobacterium bovis BCG in mice.
    Jeevan A; Asherson GL
    Infect Immun; 1988 Mar; 56(3):660-4. PubMed ID: 3277917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Local immune response to Mycobacterium lepraemurium in C3H and C57Bl/6 mice.
    Lagrange PH; Hurtrel B
    Clin Exp Immunol; 1979 Dec; 38(3):461-74. PubMed ID: 394891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Importance of T cells, gamma interferon, and tumor necrosis factor in immune control of the rapid grower Mycobacterium abscessus in C57BL/6 mice.
    Rottman M; Catherinot E; Hochedez P; Emile JF; Casanova JL; Gaillard JL; Soudais C
    Infect Immun; 2007 Dec; 75(12):5898-907. PubMed ID: 17875636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macrophage activity in resistant and susceptible mouse strains infected with Mycobacterium lepraemurium.
    Brett SJ; Butler R
    Immunology; 1988 Apr; 63(4):701-6. PubMed ID: 3284817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of route of Mycobacterium lepraemurium injection on susceptibility to mouse leprosy and on lymphoblastic transformation.
    Turcotte R
    Infect Immun; 1980 Jun; 28(3):660-8. PubMed ID: 6995320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deficit of interleukin 2 production associated with impaired T-cell proliferative responses in Mycobacterium lepraemurium infection.
    Hoffenbach A; Lagrange PH; Bach MA
    Infect Immun; 1983 Jan; 39(1):109-16. PubMed ID: 6337092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Macrophages and protective immunity in Mycobacterium lepraemurium infections in a 'resistant' (C57Bl) and a 'susceptible' (BALB/c) mouse strain.
    Preston PM
    Clin Exp Immunol; 1982 Feb; 47(2):243-52. PubMed ID: 6804142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Local reactivity, local resistance and systemic dissemination in Mycobacterium lepraemurium (MLM) infection.
    Løvik M; Closs O
    Clin Exp Immunol; 1989 Mar; 75(3):461-5. PubMed ID: 2649294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth of Mycobacterium lepraemurinum in the mouse bone marrow: an ultrastructural study.
    Brown IN; Draper P
    Infect Immun; 1976 Apr; 13(4):1199-204. PubMed ID: 776832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study of DTH and resistance in Mycobacterium lepraemurium infection using a T-cell line isolated from mice infected with Mycobacterium bovis (BCG).
    Hussein S; Curtis J; Griffiths D; Turk JL
    Cell Immunol; 1987 Apr; 105(2):423-31. PubMed ID: 3032464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of dose and route of inoculation and of mouse strain on the production of interleukin 2 in mice infected with Mycobacterium lepraemurium.
    Hoffenbach A; Lagrange PH; Bach MA
    Acta Leprol; 1984; 2(2-4):413-20. PubMed ID: 6398600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of cell-mediated immunity to Mycobacterium lepraemurium in susceptible mice.
    Lefford MJ; Patel PJ; Poulter LW; Mackaness GB
    Infect Immun; 1977 Dec; 18(3):654-9. PubMed ID: 338487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation of cytolytic T lymphocytes in thymectomized, irradiated, and bone marrow-reconstituted mice.
    Duprez V; Hamilton B; Burakoff SJ
    J Exp Med; 1982 Sep; 156(3):844-59. PubMed ID: 6125557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Macrophage activation in mice infected with Mycobacterium lepraemurium.
    Brett SJ
    Acta Leprol; 1984; 2(2-4):379-86. PubMed ID: 6398596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.